Protein Alternatives (@ProAlt2006) header
Protein Alternatives (@ProAlt2006) profile picture

ProAlt is a biotechnological company focused on the development and commercialization of biomarker-based assays for cancer diagnosis and clinical management.

Community of Madrid, Spain
Joined March 2017
Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)Photo by Protein Alternatives (@ProAlt2006)
🚀 PROTEIN ALTERNATIVES joins #SEPSENS, a collaborative project developing next-generation CRISPR-based electrochemical biosensors for early sepsis detection and antimicrobial resistance (AMR) identification through multiparametric Point-of-Care platforms.
1
2
11
🔬 La semana pasada, PROALT patrocinó en la @urjc el evento “Hacia la medicina de precisión en cáncer de colon”, con participación de Custodia García Jiménez, José Manuel González Sancho, Rocío Díaz Sánchez, Natalia Pendás Franco y nuestro CEO, Juan Ignacio Imbaud. 👉
97
🚀 Protein Alternatives will be be presenting at #BioTrinity2025 in Science Track 1! 📅 April 2 | 🕝 14:30-16:00 🔬 Science Spotlight Thirteen – New Platforms & Technologies for Drug Discovery See you in London! ✨ #DrugDiscovery #Biotech #Innovation #ProteinAlternatives
15
Protein Alternatives Welcomes Dr Antoni Castells Garangou, MD, PhD, to our Scientific Advisory Board proteinalternatives.com/prot… #Welcome #Oncology #ProteinAlternatives
12
Protein Alternatives Welcomes Prof. Eric Van Cutsem, MD, PhD, to our Scientific Advisory Board proteinalternatives.com/prot… #Welcome #Oncology #ProteinAlternatives
12
Protein Alternatives welcomes back Hugo Cartagena in his new role as COO proteinalternatives.com/prot… #WelcomeBack #Biotechnology #ProteinAlternatives
16
ProAlt was selected by the European Innovation Council (@EUeic) to participate in the EIC Corporate Day with Merck (@merckgroup)
1
3
Patient-friendly presentations on a variety of topics related to #colorectalcancer are available from our virtual #Congress2020. Check out gccacongress.org. Did we mention it's 100% free? Enjoy the presentations and reach out to us with any ?s on socials info@globalcca.org
El proceso de validación de centros que colaboren en el diagnóstico con PCR continúa en el #ISCIII. Hay más laboratorios en fases avanzadas de capacitación que, tras garantizar requisitos de seguridad y recursos, podrían sumarse a corto plazo a los 13 centros ya validados. ⬇️
El @SaludISCIII ha validado la capacitación de 8 nuevos centros de investigación y universidades para que puedan realizar test de PCR. Ya hay un total de 13 centros o universidades validados para la realización de pruebas de diagnóstico del #COVID19. ➡️https://xitter.cf/t.co/DiHHeF1FxB
9
93
3
148
According to public health researchers at Harvard University, the overall duration of SARS-CoV-2 epidemic could last into 2022, and we may need to maintain social distancing until 2022 and follow-up of infections until 2024. science.sciencemag.org/conte…
Protein Alternatives retweeted
Me he reunido con varias empresas biotecnológicas para abordar la producción de kits diagnósticos. Tienen la experiencia en I+D para fabricarlos. Hemos conversado sobre cómo hacer más desarrollos, asegurar los suministros y cómo podría ayudar el Gobierno. https://xitter.cf/t.co/gysF4ncl0C
44
217
13
735
Protein Alternatives retweeted
La ficha 8 de #InfoSEV sobre el #SARSCoV2 expone el curso de la enfermedad #COVID19, con sus cuatro escenarios típicos. Recordad: tanto los infectados asintomáticos como los que muestran síntomas leves o moderados (aprox, 80% del total) tb son contagiosos, durante 2-3 semanas!
5
124
5
139
Protein Alternatives retweeted
📢Announcing a new #CaixaImpulse Express Call for projects that address the #COVID19 pandemic. 🔹For projects or technologies focused on preventing, diagnosing, treating or monitoring this illness 🔹Selected projects will receive a grant of up to €300K xitter.cf/cards/p0rk…
9
9